Search for a command to run...
Influenza epidemics cause morbidity and mortality worldwide (4). Each year in the United States, more than 200,000 patients are admitted to hospitals because of influenza and there are approximately 36,000 influenza-related deaths (14). In recent years, several subtypes of avian influenza viruses have jumped host species to infect humans. The H5N1 subtype, in particular, has been reported in 328 human cases and has caused 200 human deaths in 12 countries (World Health Organization, http://www.who.int/csr/disease/avian_influenza/country/cases_table_2007_09_10/en/index.html). These viruses have the potential to cause a pandemic in humans. Antiviral drugs and vaccines must be developed to minimize the damage that such a pandemic would bring. To achieve this, it is vital that researchers have free access to viral sequences in a timely fashion, and sequence analysis tools need to be readily available. Historically, the number of influenza virus sequences in public databases has been far less than those of some well-studied viruses, such as human immunodeficiency virus. The number of complete influenza virus genomes has been even smaller. In addition, many of the sequences were collected in the course of influenza surveillance programs that prioritized antigenically novel isolates. Although collecting antigenically novel isolates is appropriate for surveillance, it results in biased samples of sequenced isolates that are not representative of community cases of influenza (2, 13). Therefore, in 2004, the National Institute of Allergy and Infectious Diseases (NIAID) launched the Influenza Genome Sequencing Project (7), which aims to rapidly sequence influenza viruses from samples collected all over the world. Viral sequences were generated at the J. Craig Venter Institute, annotated at the National Center for Biotechnology Information (NCBI), and deposited in GenBank. In just over 2 years after the initiation of the project, more than 2,000 complete genomes of influenza viruses A and B had been deposited in GenBank. To help the research community to make full use of the wealth of information from such a large amount of data, which will be increasing continuously, the Influenza Virus Resource was created at NCBI in 2004.